Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
2X HyperFusion High-Fidelity Master Mix Drives Precision PCR
2026-05-29
2X HyperFusion™ High-Fidelity Master Mix sets a new standard for high-fidelity PCR, uniquely enabling error-sensitive workflows like CRISPR/Cas9-mediated gene editing and immunotherapy research. Its robust performance and streamlined protocol empower researchers to achieve superior accuracy and reproducibility in cloning and advanced molecular diagnostics.
-
CD163+ Macrophage Activation Drives Granulosa Cell Apoptosis
2026-05-29
This study uncovers the mechanistic role of CD163+ macrophage activation and elevated CD163 expression in inducing granulosa cell apoptosis within polycystic ovary syndrome (PCOS). By integrating transcriptomic analysis, human clinical samples, and a DHEA-induced PCOS mouse model, the research highlights macrophage-mediated inflammation as a pivotal contributor to ovarian dysfunction, offering a refined target for future therapeutic strategies.
-
Tubastatin A Reduces Myocardial Pyroptosis After Cardiac Arr
2026-05-28
A recent experimental study demonstrates that Tubastatin A, a selective HDAC6 inhibitor, can attenuate post-resuscitation myocardial damage by suppressing GSDME-mediated pyroptosis and MLKL-mediated necroptosis in a porcine cardiac arrest model. These findings clarify the mechanistic role of HDAC6 inhibition in limiting cardiac injury following ischemia-reperfusion and highlight new translational avenues for targeting programmed cell death pathways in myocardial protection.
-
Bioinformatics and Experimental Validation of CRC Prognostic
2026-05-28
Huang et al. (2025) integrated large-scale bioinformatics with experimental validation to identify and confirm a five-gene prognostic signature, highlighting TIMP1 as a key biomarker in colorectal cancer. Their approach refines prognostic modeling for CRC and emphasizes the translational value of robust RNA analysis methods.
-
12-O-tetradecanoyl phorbol-13-acetate: ERK/MAPK Pathway Acti
2026-05-27
12-O-tetradecanoyl phorbol-13-acetate (TPA) is a potent and reliable activator of the ERK/MAPK signaling pathway, primarily through protein kinase C modulation. TPA is widely used in signal transduction research and skin cancer models due to its rapid, tunable effects and robust benchmark data. Its storage, solubility, and experimental handling are well-defined, ensuring reproducible results in preclinical and mechanistic studies.
-
Tubastatin A Attenuates Post-Resuscitation Cardiac Injury vi
2026-05-27
A recent porcine study demonstrates that Tubastatin A, a highly selective HDAC6 inhibitor, mitigates myocardial injury after cardiac arrest and resuscitation by suppressing both GSDME-mediated pyroptosis and MLKL-mediated necroptosis. These findings provide mechanistic insight into HDAC6 inhibition as a strategy for cardioprotection following ischemia-reperfusion injury.
-
Disodium Bicinchoninate in Cardiac Fibrosis Assays: Mechanis
2026-05-26
Explore how disodium bicinchoninate, a water-soluble small molecule, advances cardiac fibrosis and apoptosis research. This article provides mechanistic depth, unique protocol guidance, and context from recent landmark studies.
-
Decoding Dual-Fluorescence: EZ Cap™ Cy5 EGFP mRNA (5-moUTP)
2026-05-26
Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) redefines Cy5-labeled mRNA delivery with dual-fluorescence quantification and immune evasion. This in-depth analysis uniquely bridges mechanistic insight with assay optimization strategies.
-
Artesunate in Cancer Research: Integrative Mechanisms and In
2026-05-25
Explore Artesunate, a potent artemisinin derivative, as a multifaceted tool for in vitro cancer research. This article uniquely connects mechanistic insight to assay strategy, helping researchers optimize experimental design and interpretation.
-
Shufeng Xingbi Therapy Modulates Th1/Th2 Balance and Gut Flo
2026-05-25
The reference study demonstrates that Shufeng Xingbi Therapy significantly alleviates allergic rhinitis (AR) symptoms in rats by restoring Th1/Th2 immune balance and reshaping intestinal microbiota. These findings provide mechanistic insight into the therapy’s dual immunomodulatory and microbiota-targeting effects, supporting its potential as an experimental model for immune-allergy research.
-
G418 Sulfate (Geneticin): Selective Power & Antiviral Benchm
2026-05-24
G418 Sulfate (Geneticin) is a potent genetic engineering selection antibiotic with well-characterized ribosomal inhibition and emerging antiviral activity. Its dual functionality—precise selection for neomycin-resistant cells and inhibition of Dengue virus—makes it indispensable for cell line development and virology workflows. This article details verifiable mechanisms, application boundaries, and protocol parameters.
-
Pemetrexed Disodium: Advanced Insights for DNA Repair Defect
2026-05-23
Explore how pemetrexed disodium, a multi-targeted antifolate, enables next-generation research into DNA repair defects and chemoresistance in cancer models. This in-depth analysis reveals unique protocol strategies and translational outlooks for using pemetrexed in complex tumor biology.
-
Trelagliptin Promotes RUNX2-Driven Osteoblastic Differentiat
2026-05-22
This study reveals that trelagliptin, a DPP-4 inhibitor, enhances osteoblastic differentiation by upregulating RUNX2 via an AMPK-dependent pathway in MC3T3-E1 cells. The findings suggest a novel therapeutic implication for osteoporosis, expanding the potential utility of trelagliptin beyond glycemic control.
-
KR-12 Human Antimicrobial Peptide: Applied Research & Protoc
2026-05-22
KR-12 (human) TFA is the minimal LL-37-derived antimicrobial peptide, uniquely balancing potent anti-biofilm, LPS-neutralizing, and low-cytotoxicity properties for translational infection models. This article details actionable experimental workflows, troubleshooting strategies, and advanced use-cases, empowering researchers to harness KR-12's multi-functional bioactivity with confidence.
-
mTORC1-IRE1α Pathway Drives Palmitate-Induced Hepatocyte Inj
2026-05-21
This study uncovers a mechanistic link between mTORC1 activation and IRE1α-mediated endoplasmic reticulum stress in hepatocytes exposed to saturated fatty acids. The findings clarify how palmitate triggers triglyceride overproduction and cell death, highlighting new targets for metabolic disorder therapies.